​​​​Faraidoon Haghdoost

Last night, I had the opportunity to join Philip Clark on the Nightlife on ABC Radio for a one-hour live discussion on headache disorders and emerging research. I was also joined by Jason Ray from Monash University. Jason joined from the Melbourne studio, while I was in Sydney, and together we explored a range of important topics, including diagnosis, treatment challenges, and ongoing research in the field. One of the most valuable parts of the program was the interaction wit

I recently had the opportunity to present my work on cluster headache ( Cluster Headache gaps and future trials) , including findings from our 2026 study on patient perspectives in Australia and an overview of our upcoming PEACE trial exploring psilocybin as a potential treatment. It was a great session hosted by the Australia New Zealand Cluster Headache Support, with strong engagement from the community and meaningful discussions around lived experience, unmet needs, and f

Australians living with cluster headache, one of the most painful conditions known to medicine, are calling for research into psilocybin. A new survey has found that 82% of participants want clinical trials of the psychoactive compound found in magic mushrooms. The findings, published in Headache: The Journal of Head and Face Pain , reveal deep dissatisfaction with current treatment options. Only 6% of the 202 participants surveyed considered their treatment "very effective,"

It was a real pleasure to chat with Amber Cunningham on ABC Perth Radio about our newly funded Psilocybin Efficacy and Acceptability on Cluster Headache Episodes (PEACE) study . This exciting clinical trial — one of the first of its kind — will investigate whether psilocybin , the active compound found in certain mushrooms, can help prevent or reduce the frequency of cluster headache attacks . Cluster headache is one of the most severe and disabling pain conditions known, o